Insulet Corporation is a medical device company that develops, manufactures, and sells innovative insulin delivery systems, primarily through its Omnipod product platform, for people with insulin-depe... Insulet Corporation is a medical device company that develops, manufactures, and sells innovative insulin delivery systems, primarily through its Omnipod product platform, for people with insulin-dependent diabetes worldwide. The Omnipod offers a tubeless, wearable Pod that provides up to three days of continuous insulin delivery without needles or tubing, simplifying diabetes management and eliminating multiple daily injections. Key products include the Omnipod 5 Automated Insulin Delivery system, which integrates with third-party continuous glucose monitors via Bluetooth for automated insulin adjustments, and the Omnipod DASH insulin management system controlled by a smartphone-like device. Insulet Corporation also adapts its Pod technology for the subcutaneous delivery of non-insulin drugs in other therapeutic areas through partnerships. Available in over 25 countries across North America, Europe, the Middle East, and Asia Pacific, the company focuses on enhancing patient freedom and reducing the daily burden of diabetes care. Founded in 2000 and headquartered in Acton, Massachusetts, Insulet Corporation leads in tubeless automated insulin delivery solutions.Show lessShow more

Disclosures ESG Data Financial Data

Income Statement Balance Sheet Group Entities

Data not available

Group Entities data not yet covered for Insulet

We have not yet reviewed Insulet's disclosures for Group Entities data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review Insulet's data?

Start your 30-day free trial to request a data review for Insulet.

Start Free Trial

Legal Center Contact Us

Insulet Corp

Group Entities data not yet covered for Insulet

Account Restricted